Heba Abdelrasheed Allam

Design and Synthesis of some new 2,4,6-trisubstituted quinazoline EGFR inhibitors as targeted anticancer agents

Heba Abdelrasheed Allam, Enayat E. Aly, Ahmed K.B.A.W. Farouk et al. · Bioorganic Chemistry · 2020 · 89 citations

Medicinal Chemistry, Drug Targeting, Medicine +10

Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform

Hany S. Ibrahim, Heba Abdelrasheed Allam, Walaa R. Mahmoud et al. · European Journal of Medicinal Chemistry · 2018 · 69 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +11

Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease

Kamilia M. Amin, Doaa E. Abdel Rahman, Heba Abdelrasheed Allam et al. · Bioorganic Chemistry · 2021 · 43 citations

Medicinal Chemistry, Derivative (Chemistry), Alzheimer's Disease +10

Synthesis and biological evaluation of some novel thiobenzimidazole derivatives as anti-renal cancer agents through inhibition of c-MET kinase

Hany S. Ibrahim, Mohamed E. Albakri, Walaa R. Mahmoud et al. · Bioorganic Chemistry · 2019 · 31 citations

Medicinal Chemistry, C-met Kinase, Novel Thiobenzimidazole Derivatives +10

Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX

Heba Abdelrasheed Allam, Samar H. Fahim, Mahmoud F. Abo-Ashour et al. · European Journal of Medicinal Chemistry · 2019 · 27 citations · Full text

Medicinal Chemistry, Hydrazido Linkers, Biochemistry +11